Modulation of enrofloxacin binding in OmpF by Mg2+ as revealed by the analysis of fast flickering single-porin current.
One major determinant of the efficacy of antibiotics on gram-negative bacteria is the passage through the outer membrane. During transport of the fluoroquinolone enrofloxacin through the trimeric outer membrane protein OmpF of Escherichia coli, the antibiotic interacts with two binding sites within the pore, thus partially blocking the ionic current. The modulation of one affinity site by Mg(2+) reveals further details of binding sites and binding kinetics. At positive membrane potentials, the slow blocking events induced by enrofloxacin in Mg(2+)-free media are converted to flickery sojourns at the highest apparent current level (all three pores flickering). This indicates weaker binding in the presence of Mg(2+). Analysis of the resulting amplitude histograms with β distributions revealed the rate constants of blocking (k(OB)) and unblocking (k(BO)) in the range of 1,000 to 120,000 s(-1). As expected for a bimolecular reaction, k(OB) was proportional to blocker concentration and k(BO) independent of it. k(OB) was approximately three times lower for enrofloxacin coming from the cis side than from the trans side. The block was not complete, leading to a residual conductivity of the blocked state being ∼25% of that of the open state. Interpretation of the results has led to the following model: fast flickering as caused by interaction of Mg(2+) and enrofloxacin is related to the binding site at the trans side, whereas the cis site mediates slow blocking events which are also found without Mg(2+). The difference in the accessibility of the binding sites also explains the dependency of k(OB) on the side of enrofloxacin addition and yields a means of determining the most plausible orientation of OmpF in the bilayer. The voltage dependence suggests that the dipole of the antibiotic has to be adequately oriented to facilitate binding.
Research Center Borstel, Division of Biophysics, 23845 Borstel, Germany.
Annemarie
A
Brauser
Indra
I
Schroeder
Thomas
T
Gutsmann
Cristian
C
Cosentino
Anna
A
Moroni
Ulf-Peter
UP
Hansen
Mathias
M
Winterhalter
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001665:Binding Sites; D000077422:Enrofloxacin; D024841:Fluoroquinolones / Q000494:pharmacology*; D015640:Ion Channel Gating / Q000187:drug effects; D008051:Lipid Bilayers / Q000737:chemistry; D008274:Magnesium / Q000378:metabolism; D008958:Models, Molecular; D018408:Patch-Clamp Techniques; D018272:Porins / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D008051:Lipid Bilayers; C109237:OmpF protein; D018272:Porins; D000077422:Enrofloxacin; D008274:Magnesium